I was intrigued that Rohan mentioned at least twice that the Australian investment community and the US were looking to quite different outcomes. Does this mean the Australian owners are looking to sell access to the platform while the US investors want to buy a share of the platform? Or, is something else at play? To me there seemed a coyness around the whole US thing. No Sahm, Kaggan, Roseblatt during Rohans presentation while Rohan mentioned that the Nasdaq listing was a lot more difficult than envisaged. Interesting days ahead and not just from a science viewpoint.
- Forums
- ASX - By Stock
- PYC
- Ann: 2021 AGM Chairman's Address and CEO Presentation
Ann: 2021 AGM Chairman's Address and CEO Presentation, page-20
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 118941 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 183634 | 2 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online